Lumida
/CAPR
⌘K
Capricor Therapeutics Inc

Capricor Therapeutics Inc

CAPR
$8.37USD+0.84%+0.07 today

MARKET CAP

486.6M

P/E (TTM)

FWD P/E

DAY RANGE

$8 – $9

52W RANGE

$3
$40

AI Summary

Stalk
StalkMedium

CAPR remains in a deep Stage 4 decline with all moving averages sloping downward and price trading below key MAs. Extreme oversold readings suggest a tactical bounce, but the long-term trend stays bearish. Mean-reversion eligibility forces a bullish medium-term bias, permitting only countertrend entries. Short-term execution is deferred until we see support confirmation or an initial relief rally into falling EMAs.

  • Share price jumped 97% post-FDA application amendment; Cantor Fitzgerald set $28 target.
  • HOPE-3 data showed Deramiocel slowed DMD upper-limb decline by 54%.
  • Q2 operating expenses rose 55% YoY to $42.9 M, driving a $40.7 M net loss ($0.70/share).
Full analysis →
Insider Trades14 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 25, 2026SellCAPRAnthony BergmannCHIEF FINANCIAL OFFICER48,200$16.78$486.6M-79.27%+182.77%$808.8K+0.00%10b5-1Trim
Jun 25, 2026SellCAPRKaren KrasneyEVP, GENERAL COUNSEL48,200$16.78$486.6M-79.27%+182.77%$808.8K+0.00%10b5-1Trim
Jun 22, 2026SellCAPRAnthony BergmannCHIEF FINANCIAL OFFICER1,800$16.59$486.6M-79.27%+182.77%$29.9K+0.00%10b5-1Trim
Jun 22, 2026SellCAPRKaren KrasneyEVP, GENERAL COUNSEL1,800$16.59$486.6M-79.27%+182.77%$29.9K+0.00%10b5-1Trim
May 18, 2026BuyCAPRAnthony BergmannCHIEF FINANCIAL OFFICER3,000$1.39$486.6M-79.27%+182.77%$4.2K+36.48%Trim
May 1, 2026SellCAPRAnthony BergmannCHIEF FINANCIAL OFFICER50,000$17.44$486.6M-79.27%+182.77%$872.0K+0.00%10b5-1Trim
May 1, 2026SellCAPRKaren KrasneyEVP, GENERAL COUNSEL50,000$17.44$486.6M-79.27%+182.77%$872.0K+0.00%10b5-1Trim
Mar 31, 2026SellCAPRAnthony BergmannCHIEF FINANCIAL OFFICER50,000$16.65$486.6M-79.27%+182.77%$832.7K+0.00%10b5-1Trim
Mar 31, 2026SellCAPRKaren KrasneyEVP, GENERAL COUNSEL50,000$16.86$486.6M-79.27%+182.77%$843.2K+0.00%10b5-1Trim
Dec 30, 2025BuyCAPRKaren KrasneyEVP, GENERAL COUNSEL2,500$1.39$486.6M-79.27%+182.77%$3.5K+8.91%Trim
Mar 3, 2025BuyCAPRAnthony BergmannCHIEF FINANCIAL OFFICER2,500$1.39$486.6M-79.27%+182.77%$3.5K+43.68%Trim
Mar 3, 2025BuyCAPRLinda MarbanCHIEF EXECUTIVE OFFICER25,000$1.39$486.6M-79.27%+182.77%$34.8K+12.59%Trim
Dec 13, 2024BuyCAPRKaren KrasneyEVP, GENERAL COUNSEL8,000$1.39$486.6M-79.27%+182.77%$11.1K+39.91%Trim
Oct 23, 2023BuyCAPRAnthony BergmannCHIEF FINANCIAL OFFICER2,178$1.39$486.6M-79.27%+182.77%$3.0K+1072.91%Trim